.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, Dr. Norm's concentrated 65.56% of sales in Edible, where category sales rose 11.12% month over month but declined 1.74% year over year, while Capsules expanded to 25.67% share with a 1.73% MoM gain and a 4,818.81% YoY surge, and Vapor Pens held 8.77% share with a 4.99% MoM decline and a 15.03% YoY decline. Average price in May 2026 was up 0.14% year over year, and Edible held a rank of 15 in California, implying the mix shift is driven more by unit momentum in Capsules and seasonal MoM demand in Edible than by price changes.
The rapid Capsules expansion (share at 25.67% alongside a 4,818.81% YoY increase) combined with Edible’s 11.12% MoM uptick and 1.74% YoY dip indicates a pivot toward formats with higher average price points (Capsules at $21.35 vs. Edible at $10.45) and away from Vapor Pens, which declined 4.99% MoM and 15.03% YoY. Holding rank 15 in California Edible while Capsules scale suggests the brand is using Edible as a volume base while migrating premium mix into Capsules, which could elevate average realized price and margin if the Capsules share sustains or grows another 2–3 percentage points over the next few months.
Competitive Landscape
Dr. Norm's sits at rank 15 in CA Edible for May 2026, a 1-place improvement from rank 16 one year ago, and a 2-place lift versus rank 17 three months ago; however, it remains 1 place below its peak rank of 14 from January 2025, and trails the category leaders where Wyld held rank 1 year-over-year while posting a -12.9% sales change and Good Tide advanced from rank 6 to rank 5 alongside a 14.4% sales increase. This combination of modest rank gains against a flat-to-declining leader and an advancing mid-pack rival implies Dr. Norm's is edging upward but must convert incremental rank momentum into share capture before competitors widen the gap.
Notable Products
Sleep Well - THC/CBN 2:1 Elderberry Nano Sleep Gummies 10-Pack (100mg THC, 50mg CBN) posted the largest movement in May 2026 with a 26% month-over-month increase and a rank of 3, while Sleepwell - THC/CBD/CBG/CBN Sweet Dreams Distillate Disposable (1g) slipped 7% MoM at rank 8, indicating share tilting toward ingestibles over inhalables. Indica Max Tablets 20-Pack (1000mg) held rank 1 with a 4% MoM lift and approximately $80,417 in sales, and four of the top ten are Edible SKUs spanning ranks 2, 3, 4, and 5, with Mango Madness Max Solventless Hash Gummy (100mg) up 16% MoM at rank 5 versus Wicked Watermelon Hash Gummy (100mg) down 3% MoM at rank 4. The pattern implies Dr. Norm's is consolidating leadership around functional and high-dosage ingestibles while vapor pen exposure softens, nudging the mix toward repeatable sleep and wellness use cases.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
